Home/Pipeline/US Generics Portfolio

US Generics Portfolio

Broad Therapeutic Areas

Filed/ApprovedActiveN/A (ANDA filings)

Key Facts

Indication

Broad Therapeutic Areas

Phase

Filed/Approved

Status

Active

Company

Aurobindo Pharma

About Aurobindo Pharma

Founded in 1986, Aurobindo Pharma has grown from an API manufacturer into a global generics powerhouse with a mission to make medicines affordable and accessible worldwide. Its core strategy leverages deep vertical integration, significant manufacturing scale (29 facilities producing 50+ billion formulation units annually), and a strategic pivot towards high-value complex generics, injectables, and biosimilars. Key achievements include a portfolio of over 830 ANDA filings in the US with 600+ approvals, leadership in antiretroviral therapies, and the recent inauguration of a flagship Penicillin-G facility, underscoring its commitment to backward integration and supply chain resilience.

View full company profile

Therapeutic Areas

Broad Generics Infectious Disease (HIV/AIDS, Anti-infectives)Oncology Immunology Central Nervous System Cardiovascular

Other Broad Therapeutic Areas Drugs

Drug	Company	Phase	Status
Commercial Analytics	Prognos	Commercial	Active
Precision Marketing	Prognos	Commercial	Active
Generic Portfolio Expansion	SPIMACO	Registration & Launch	Active
Merchant API Portfolio	EuroAPI	Commercial	Active Supply